c-Jun NH2-terminal kinase promotes apoptosis by down-regulating the transcriptional co-repressor CtBP

Su-Yan Wang1, Mihail Iordanov, Qinghong Zhang

  • 1Vollum Institute and Department of Cell and Developmental Biology, Oregon Health & Science University, Portland, Oregon 97239, USA.

Insights

Genetic knockout of carboxyl-terminal-binding protein (CtBP) increases apoptosis. This study shows c-Jun NH2-terminal kinase 1 (JNK1) activation degrades CtBP, inducing cancer cell apoptosis, offering a new chemotherapy target.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cell Death Pathways

Background:

  • Genetic disruption of carboxyl-terminal-binding protein (CtBP) leads to increased apoptosis.
  • Cellular CtBP levels are hypothesized to regulate apoptosis propensity.
  • Homeodomain-interacting protein kinase 2 (HIPK2) was previously identified as a CtBP regulator.

Purpose of the Study:

  • To investigate the role of c-Jun NH2-terminal kinase 1 (JNK1) in regulating CtBP levels and apoptosis.
  • To determine if JNK1-mediated CtBP degradation induces apoptosis in human lung cancer cells.
  • To explore potential therapeutic strategies targeting CtBP degradation in cancer.

Main Methods:

  • Investigated the effect of JNK1 activation on CtBP phosphorylation and degradation in human lung cancer cells.
  • Utilized UV irradiation and cisplatin to activate the JNK1 pathway.
  • Assessed CtBP levels and apoptosis induction in response to JNK1 activation and deficiency.
  • Examined the role of the proteasome-mediated pathway in CtBP degradation.

Main Results:

  • JNK1 activation triggers CtBP phosphorylation on Ser-422 and subsequent proteasomal degradation.
  • This degradation induces p53-independent apoptosis in human lung cancer cells.
  • UV irradiation and cisplatin-induced JNK1 activation reduce cellular CtBP levels.
  • JNK1 deficiency prevents CtBP degradation and apoptosis induction.

Conclusions:

  • JNK1-mediated degradation of CtBP represents a novel mechanism for inducing apoptosis.
  • Targeting the JNK1-CtBP pathway offers a potential therapeutic strategy for cancers, particularly those lacking p53.
  • This finding provides a new avenue for chemotherapy development in specific cancer types.

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Co-activators and Co-repressors02:04

Co-activators and Co-repressors

Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside cells.
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...